Overview

Rivaroxaban for Scheduled Work-up of DVT - The Ri-Schedule Study

Status:
Completed
Trial end date:
2018-12-30
Target enrollment:
Participant gender:
Summary
This prospective outcome study is designed to assess the safety of rivaroxaban in the pre-diagnosis phase of DVT.
Phase:
Phase 3
Details
Lead Sponsor:
Ostfold Hospital Trust
Treatments:
Rivaroxaban